Operating Income (Annual)

Operating Income: The income after operating expenses.

Bio-Techne Corp (TECH) had Operating Income of $251.89M for the most recently reported fiscal year, ending 2026-06-30.

Quarterly Annual

Figures for fiscal year ending 2026-06-30

Income Statement Financials
Revenue	$1.22B
Net Income	$181.86M
Cost of Goods Sold	$415.97M
Gross Profit	$799.07M
Operating Expenses	$963.15M
Operating Income	$251.89M
Non-Operating Income/Expense	$-11.21M
Pre-Tax Income	$240.68M
Normalized Pre-Tax Income	$240.68M
Income after Taxes	$181.86M
Income from Continuous Operations	$181.86M
Consolidated Net Income/Loss	$181.86M
Normalized Income after Taxes	$181.86M
EBIT	$251.89M
EBITDA	$349.25M
Weighted-Average Shares Outstanding (Basic)	155.96M
Weighted-Average Shares Outstanding (Diluted)	157.01M
Earnings per Share (EPS) (Basic)	$1.17
Earnings per Share (EPS) (Diluted)	$1.16
Balance Sheet Financials
Current Assets	$744.40M
Property, Plant, and Equipment	$231.84M
Long-Term Assets	$1.84B
Total Assets	$2.59B
Current Liabilities	$163.70M
Long-Term Debt	$200.00M
Long-Term Liabilities	$314.81M
Total Liabilities	$478.50M
Common Equity	$2.11B
Tangible Shareholders Equity	$829.40M
Shareholders Equity	$2.11B
Common Shares Outstanding	156.09M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$292.07M
Cash Flow from Investing Activities	$-18.19M
Cash Flow from Financial Activities	$-169.11M
Beginning Cash	$162.19M
End Cash	$264.71M
Increase/Decrease in Cash	$102.53M
Stock-Based Compensation	$41.37M
Common Stock Dividends Paid	$-49.92M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.55
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.09
Debt to Equity Ratio	0.09
Gross Margin	65.77%
Operating Margin	20.73%
EBIT Margin	20.73%
EBITDA Margin	28.74%
Pre-Tax Profit Margin	19.81%
Profit Margin	14.97%
Free Cash Flow	$263.22M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.47
Inventory Turnover	2.13
Receiveable Turnover	5.61
Days Sales in Receivables	65.06
Return on Equity	8.63%
Return on Tangible Equity	21.93%
Return on Assets	7.03%
Return on Investments	7.88%
Book Value Per Share	$13.51
Free Cash Flow per Share	$1.68
Operating Cash Flow per Share	$1.86

Data from Zacks Investment Research, Inc.